271 related articles for article (PubMed ID: 20506099)
1. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.
Margheri F; Serratì S; Lapucci A; Anastasia C; Giusti B; Pucci M; Torre E; Bianchini F; Calorini L; Albini A; Ventura A; Fibbi G; Del Rosso M
Neoplasia; 2009 Oct; 11(10):1106-15. PubMed ID: 19794969
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
5. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
Margheri F; Manetti M; Serratì S; Nosi D; Pucci M; Matucci-Cerinic M; Kahaleh B; Bazzichi L; Fibbi G; Ibba-Manneschi L; Del Rosso M
Arthritis Rheum; 2006 Dec; 54(12):3926-38. PubMed ID: 17133606
[TBL] [Abstract][Full Text] [Related]
6. Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis.
Giusti B; Margheri F; Rossi L; Lapini I; Magi A; Serratì S; Chillà A; Laurenzana A; Magnelli L; Calorini L; Bianchini F; Fibbi G; Abbate R; Del Rosso M
PLoS One; 2013; 8(7):e68117. PubMed ID: 23874518
[TBL] [Abstract][Full Text] [Related]
7. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells.
O'Neill CL; Guduric-Fuchs J; Chambers SE; O'Doherty M; Bottazzi B; Stitt AW; Medina RJ
Cardiovasc Res; 2016 Dec; 112(3):677-688. PubMed ID: 27659714
[TBL] [Abstract][Full Text] [Related]
9. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.
Romano E; Rosa I; Fioretto BS; Giuggioli D; Manetti M; Matucci-Cerinic M
Rheumatology (Oxford); 2023 Feb; 62(SI):SI125-SI137. PubMed ID: 35900177
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
15. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.
Shirai Y; Okazaki Y; Inoue Y; Tamura Y; Yasuoka H; Takeuchi T; Kuwana M
Arthritis Rheumatol; 2015 Feb; 67(2):498-507. PubMed ID: 25385504
[TBL] [Abstract][Full Text] [Related]
17. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in systemic sclerosis.
Altorok N; Wang Y; Kahaleh B
Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
Wang Y; Sun J; Kahaleh B
J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
